Trial Profile
Clinical Trials Insight: 700058577
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Aug 2010
Price :
$35
*
At a glance
- Drugs ADX 71149 (Primary)
- Indications Anxiety disorders; CNS disorders; Depressive disorders; Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Janssen Research & Development
- 25 Aug 2010 This trial has been completed according to an Addex Pharmaceuticals media release.
- 25 Aug 2010 New trial record